Yasuhide Kanayama

Toyota, 4700396, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Author response to the letter to the editor regarding "Hip Response to Romosozumab in Glucocorticoid Users: Beyond Systemic Bone Turnover Markers".

Author response to the letter to the editor regarding "Hip Response to Romosozumab in Glucocorticoid Users: Beyond Systemic Bone Turnover Markers".

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: June 05, 2026

Clinical and radiographic outcomes of cannulated cancellous screw osteosynthesis with and without side-plate for nondisplaced femoral neck fractures: a multicenter propensity score-matched study.

Clinical and radiographic outcomes of cannulated cancellous screw osteosynthesis with and without side-plate for nondisplaced femoral neck fractures: a multicenter propensity score-matched study.

Journal: International orthopaedics

Published: May 12, 2026

Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study.

Impact of oral glucocorticoids on the effectiveness of romosozumab: the multicenter OASIS cohort study.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: February 19, 2026

Effectiveness of denosumab, teriparatide and romosozumab for glucocorticoid-induced osteoporosis: a propensity score-matched cohort study.

Effectiveness of denosumab, teriparatide and romosozumab for glucocorticoid-induced osteoporosis: a propensity score-matched cohort study.

Journal: Rheumatology (Oxford, England)

Published: August 22, 2025

Effects of concomitant methotrexate and predictors of remission in Janus kinase inhibitor therapy for rheumatoid arthritis.

Effects of concomitant methotrexate and predictors of remission in Janus kinase inhibitor therapy for rheumatoid arthritis.

Journal: Joint bone spine

Published: April 03, 2025

Comparable Clinical Effectiveness of Baricitinib and Filgotinib in Patients With Rheumatoid Arthritis.

Comparable Clinical Effectiveness of Baricitinib and Filgotinib in Patients With Rheumatoid Arthritis.

Journal: International journal of rheumatic diseases

Published: March 22, 2025

Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.

Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial.

Journal: Arthritis research & therapy

Published: January 15, 2025

Clinical effectiveness of baricitinib and abatacept in patients with rheumatoid arthritis.

Clinical effectiveness of baricitinib and abatacept in patients with rheumatoid arthritis.

Journal: International journal of rheumatic diseases

Published: July 20, 2024

Therapy with transitions from one bone-forming agent to another: a retrospective cohort study on teriparatide and romosozumab.

Therapy with transitions from one bone-forming agent to another: a retrospective cohort study on teriparatide and romosozumab.

Journal: JBMR plus

Published: July 16, 2024

Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study.

Comparison of Denosumab with Romosozumab in the treatment of male osteoporosis: a retrospective cohort study.

Journal: Scientific reports

Published: May 15, 2024

Association between P1NP value and increases in bone mineral density in patients with postmenopausal osteoporosis treated with romosozumab.

Association between P1NP value and increases in bone mineral density in patients with postmenopausal osteoporosis treated with romosozumab.

Journal: Modern rheumatology

Published: December 06, 2023

Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study.

Reasons and risk factors for discontinuation of treatment with any biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: A long-term observational study.

Journal: Modern rheumatology

Published: April 13, 2022

Showing 1-12 of 44

Last Updated: 09/26/2026